Who makes Epidermis anesthesia?

Epidermis anesthesia is developed by National Taiwan University Hospital.

What development phase is Epidermis anesthesia in?

Epidermis anesthesia is in Phase 1.

What are the side effects of Epidermis anesthesia?

Common side effects include Nausea, Hypotension, Pruritus, Dry mouth, Sedation, Ileus.

Last reviewed 2026-04-20 · How we verify

Epidermis anesthesia

National Taiwan University Hospital · Phase 1 active Small molecule Quality 5/100

At a glance

Generic name	Epidermis anesthesia
Also known as	Emla 5% cream (Lignocaine 2.5% / Prilocaine 2.5%)
Sponsor	National Taiwan University Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Nausea
Hypotension
Pruritus
Dry mouth
Sedation
Ileus
Low urinary input

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Epidermis anesthesia CI brief — competitive landscape report
Epidermis anesthesia updates RSS · CI watch RSS
National Taiwan University Hospital portfolio CI